COVID variables in R&D	Number of employees	Total
Number of enterprises that carry out intramural R&D	Less than 10 employees	2.752
Number of enterprises that carry out intramural R&D	From 10 to 49 employees	4.509
Number of enterprises that carry out intramural R&D	From 50 to 249 employees	2.862
Number of enterprises that carry out intramural R&D	250 and more employees	1.065
Number of enterprises that carry out intramural R&D	Total	11.188
% of companies whose internal R&D expenditure was increased by COVID-19	Less than 10 employees	7,98
% of companies whose internal R&D expenditure was increased by COVID-19	From 10 to 49 employees	7,31
% of companies whose internal R&D expenditure was increased by COVID-19	From 50 to 249 employees	5,51
% of companies whose internal R&D expenditure was increased by COVID-19	250 and more employees	5,67
% of companies whose internal R&D expenditure was increased by COVID-19	Total	6,86
% of companies whose internal R&D expenditure was decreased by COVID-19	Less than 10 employees	30,45
% of companies whose internal R&D expenditure was decreased by COVID-19	From 10 to 49 employees	27,2
% of companies whose internal R&D expenditure was decreased by COVID-19	From 50 to 249 employees	26,2
% of companies whose internal R&D expenditure was decreased by COVID-19	250 and more employees	29,33
% of companies whose internal R&D expenditure was decreased by COVID-19	Total	27,95
% of companies that performed internal R&D related to COVID-19	Less than 10 employees	7,96
% of companies that performed internal R&D related to COVID-19	From 10 to 49 employees	8,25
% of companies that performed internal R&D related to COVID-19	From 50 to 249 employees	8,25
% of companies that performed internal R&D related to COVID-19	250 and more employees	11,01
% of companies that performed internal R&D related to COVID-19	Total	8,44
Total expenditure on internal R&D related to COVID-19	Less than 10 employees	8.106
Total expenditure on internal R&D related to COVID-19	From 10 to 49 employees	23.155
Total expenditure on internal R&D related to COVID-19	From 50 to 249 employees	39.162
Total expenditure on internal R&D related to COVID-19	250 and more employees	58.852
Total expenditure on internal R&D related to COVID-19	Total	129.275